{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T23:41:25Z","timestamp":1781134885155,"version":"3.54.1"},"reference-count":25,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2020,2,18]],"date-time":"2020-02-18T00:00:00Z","timestamp":1581984000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","award":["HI14C3418"],"award-info":[{"award-number":["HI14C3418"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0229299","type":"journal-article","created":{"date-parts":[[2020,2,18]],"date-time":"2020-02-18T13:35:01Z","timestamp":1582032901000},"page":"e0229299","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":14,"title":["Prognostic value of SUVmax on 18F-fluorodeoxyglucose PET\/CT scan in patients with malignant pleural mesothelioma"],"prefix":"10.1371","volume":"15","author":[{"given":"Jun Hyeok","family":"Lim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joon Young","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunjoo","family":"Im","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongseok","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byung Woo","family":"Jhun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3124-1718","authenticated-orcid":true,"given":"Byeong-Ho","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye Yun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyungjong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hojoong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O Jung","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joungho","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myung-Ju","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jhingook","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9765-9068","authenticated-orcid":true,"given":"Sang-Won","family":"Um","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,2,18]]},"reference":[{"issue":"18","key":"pone.0229299.ref001","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1200\/JCO.2008.20.3943","article-title":"Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesothelioma","volume":"27","author":"LM Krug","year":"2009","journal-title":"Journal of Clinical Oncology"},{"issue":"1","key":"pone.0229299.ref002","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1186\/s13014-015-0575-5","article-title":"Long-term results in malignant pleural mesothelioma treated with neoadjuvant chemotherapy, extrapleural pneumonectomy and intensity-modulated radiotherapy","volume":"10","author":"C Thieke","year":"2015","journal-title":"Radiation Oncology"},{"issue":"8","key":"pone.0229299.ref003","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S1470-2045(11)70149-8","article-title":"Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study","volume":"12","author":"T Treasure","year":"2011","journal-title":"The lancet oncology"},{"issue":"3","key":"pone.0229299.ref004","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.thorsurg.2016.04.003","article-title":"Current treatment of mesothelioma: extrapleural pneumonectomy versus pleurectomy\/decortication","volume":"26","author":"AS Wolf","year":"2016","journal-title":"Thoracic surgery clinics"},{"issue":"14","key":"pone.0229299.ref005","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","article-title":"Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma","volume":"21","author":"NJ Vogelzang","year":"2003","journal-title":"Journal of clinical oncology"},{"key":"pone.0229299.ref006","unstructured":"Network NCC. NCCN malignant pleural mesothelioma guidelines, version 1.2020 Nov 27, 2019. Available from: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/mpm.pdf."},{"issue":"2","key":"pone.0229299.ref007","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S1470-2045(18)30765-4","article-title":"Nivolumab or nivolumab plus ipilimumab in patients with relapsed malignant pleural mesothelioma (IFCT-1501 MAPS2): a multicentre, open-label, randomised, non-comparative, phase 2 trial","volume":"20","author":"A Scherpereel","year":"2019","journal-title":"The Lancet Oncology"},{"issue":"3","key":"pone.0229299.ref008","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S2213-2600(18)30420-X","article-title":"Ipilimumab and nivolumab in the treatment of recurrent malignant pleural mesothelioma (INITIATE): results of a prospective, single-arm, phase 2 trial","volume":"7","author":"MJ Disselhorst","year":"2019","journal-title":"The Lancet Respiratory Medicine"},{"issue":"5","key":"pone.0229299.ref009","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S1470-2045(17)30169-9","article-title":"Clinical safety and activity of pembrolizumab in patients with malignant pleural mesothelioma (KEYNOTE-028): preliminary results from a non-randomised, open-label, phase 1b trial","volume":"18","author":"EW Alley","year":"2017","journal-title":"The Lancet Oncology"},{"issue":"3","key":"pone.0229299.ref010","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1378\/chest.113.3.723","article-title":"Factors predictive of survival among 337 patients with mesothelioma treated between 1984 and 1994 by the Cancer and Leukemia Group B","volume":"113","author":"JE Herndon","year":"1998","journal-title":"Chest"},{"issue":"1","key":"pone.0229299.ref011","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1200\/JCO.1998.16.1.145","article-title":"Prognostic factors in patients with pleural mesothelioma: the European Organization for Research and Treatment of Cancer experience","volume":"16","author":"D Curran","year":"1998","journal-title":"Journal of Clinical Oncology"},{"issue":"4","key":"pone.0229299.ref012","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.jtcvs.2006.03.068","article-title":"Positron emission tomography predicts survival in malignant pleural mesothelioma","volume":"132","author":"RM Flores","year":"2006","journal-title":"The Journal of thoracic and cardiovascular surgery"},{"issue":"28","key":"pone.0229299.ref013","doi-asserted-by":"crossref","first-page":"4587","DOI":"10.1200\/JCO.2006.06.8999","article-title":"Early response evaluation in malignant pleural mesothelioma by positron emission tomography with [18F] fluorodeoxyglucose","volume":"24","author":"GL Ceresoli","year":"2006","journal-title":"Journal of Clinical Oncology"},{"issue":"7","key":"pone.0229299.ref014","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1097\/JTO.0b013e3182519d96","article-title":"High SUVmax on FDG-PET indicates pleomorphic subtype in epithelioid malignant pleural mesothelioma: supportive evidence to reclassify pleomorphic as nonepithelioid histology","volume":"7","author":"K Kadota","year":"2012","journal-title":"Journal of Thoracic Oncology"},{"issue":"4","key":"pone.0229299.ref015","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1093\/annonc\/mds537","article-title":"Prognostic significance of metabolic response by positron emission tomography after neoadjuvant chemotherapy for resectable malignant pleural mesothelioma","volume":"24","author":"Y Tsutani","year":"2012","journal-title":"Annals of oncology"},{"issue":"2","key":"pone.0229299.ref016","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1007\/s00259-013-2561-1","article-title":"The association of 18 F-FDG PET\/CT parameters with survival in malignant pleural mesothelioma","volume":"41","author":"A Klabatsa","year":"2014","journal-title":"European journal of nuclear medicine and molecular imaging"},{"issue":"5","key":"pone.0229299.ref017","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s00259-014-2960-y","article-title":"Quantitative analyses at baseline and interim PET evaluation for response assessment and outcome definition in patients with malignant pleural mesothelioma","volume":"42","author":"E Lopci","year":"2015","journal-title":"European journal of nuclear medicine and molecular imaging"},{"issue":"2","key":"pone.0229299.ref018","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jtho.2015.10.003","article-title":"Contemporary analysis of prognostic factors in patients with unresectable malignant pleural mesothelioma","volume":"11","author":"A Bill\u00e9","year":"2016","journal-title":"Journal of Thoracic Oncology"},{"issue":"6","key":"pone.0229299.ref019","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s11307-009-0203-6","article-title":"Prognostic value of 18 F-FDG PET\/CT in patients with malignant pleural mesothelioma","volume":"11","author":"S Lee","year":"2009","journal-title":"Molecular Imaging and Biology"},{"issue":"12","key":"pone.0229299.ref020","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1016\/j.jtho.2016.08.147","article-title":"The IASLC Mesothelioma Staging Project: proposals for revisions of the T descriptors in the forthcoming eighth edition of the TNM classification for pleural mesothelioma","volume":"11","author":"AK Nowak","year":"2016","journal-title":"Journal of Thoracic Oncology"},{"issue":"3","key":"pone.0229299.ref021","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.crad.2018.12.010","article-title":"Evaluation of a diagnostic 18F-FDG PET\/CT strategy for differentiating benign from malignant retroperitoneal soft-tissue masses","volume":"74","author":"C Lim","year":"2019","journal-title":"Clinical radiology"},{"issue":"8","key":"pone.0229299.ref022","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.ejca.2012.01.016","article-title":"Relationship between 18F-FDG uptake on positron emission tomography and molecular biology in malignant pleural mesothelioma","volume":"48","author":"K Kaira","year":"2012","journal-title":"European Journal of Cancer"},{"issue":"10","key":"pone.0229299.ref023","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1097\/JTO.0b013e31815608d9","article-title":"Prognostic factors in the treatment of malignant pleural mesothelioma at a large tertiary referral center","volume":"2","author":"RM Flores","year":"2007","journal-title":"Journal of Thoracic Oncology"},{"issue":"1","key":"pone.0229299.ref024","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.cllc.2012.03.011","article-title":"Validation of prognostic factors in malignant pleural mesothelioma: a retrospective analysis of data from patients seeking compensation from the New South Wales Dust Diseases Board","volume":"14","author":"SC Kao","year":"2013","journal-title":"Clinical lung cancer"},{"issue":"2","key":"pone.0229299.ref025","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/bjc.2014.312","article-title":"Prognostic factors in elderly patients with malignant pleural mesothelioma: results of a multicenter survey","volume":"111","author":"G Ceresoli","year":"2014","journal-title":"British journal of cancer"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0229299","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,18]],"date-time":"2020-02-18T13:35:26Z","timestamp":1582032926000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0229299"}},"subtitle":[],"editor":[{"given":"Andrea S.","family":"Wolf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,2,18]]},"references-count":25,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,2,18]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0229299","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.737397257.793571668","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,18]]}}}